Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Point Biopharma Global Inc (PNT)

Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Point Biopharma Global Inc 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 USA

www.pointbiopharma.com P: 317-543-9957

Description:

POINT Biopharma Global Inc. is a radiopharmaceutical company. It builds a platform for the clinical development and commercialization of radioligands which fight cancer. POINT Biopharma Global Inc., formerly known as Research Alliance Corp., is based in INDIANAPOLIS.

Key Statistics

Overview:

Market Capitalization, $K 1,332,113
Enterprise Value, $K 1,045,683
Shares Outstanding, K 106,569
Annual Sales, $ 226,580 K
Annual Net Income, $ 98,290 K
Last Quarter Sales, $ 2,790 K
Last Quarter Net Income, $ -24,770 K
EBIT, $ -118,810 K
EBITDA, $ -119,370 K
60-Month Beta 0.00
% of Insider Shareholders 16.00%
% of Institutional Shareholders 59.53%
Float, K 89,518
% Float 84.00%
Short Volume Ratio 0.60

Growth:

1-Year Return 81.69%
3-Year Return -10.20%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/13/23
Next Earnings Date N/A
Earnings Per Share ttm 0.90
EPS Growth vs. Prev Qtr 4.17%
EPS Growth vs. Prev Year 11.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PNT Ratios

Ratio
Price/Earnings ttm 13.87
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 21.10%
Return-on-Assets % 18.28%
Profit Margin % 43.38%
Debt/Equity 0.00
Price/Sales 5.87
Price/Cash Flow 13.31
Price/Book 3.12
Book Value/Share 4.01
Interest Coverage 7.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar